Bahl & Gaynor’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $399K | Hold |
5,098
| – | – | ﹤0.01% | 297 |
|
|
2025
Q1 | $370K | Hold |
5,098
| – | – | ﹤0.01% | 306 |
|
|
2024
Q4 | $377K | Hold |
5,098
| – | – | ﹤0.01% | 300 |
|
|
2024
Q3 | $336K | Hold |
5,098
| – | – | ﹤0.01% | 310 |
|
|
2024
Q2 | $471K | Hold |
5,098
| – | – | ﹤0.01% | 284 |
|
|
2024
Q1 | $487K | Sell |
5,098
-197
| -4% | -$18.8K | ﹤0.01% | 286 |
|
|
2023
Q4 | $404K | Buy |
+5,295
| New | +$404K | ﹤0.01% | 294 |
|
|
2023
Q3 | – | Sell |
-3,194
| Closed | -$301K | – | 339 |
|
|
2023
Q2 | $301K | Buy |
3,194
+164
| +5% | +$15.5K | ﹤0.01% | 309 |
|
|
2023
Q1 | $251K | Sell |
3,030
-335
| -10% | -$27.7K | ﹤0.01% | 317 |
|
|
2022
Q4 | $251K | Buy |
3,365
+193
| +6% | +$14.4K | ﹤0.01% | 314 |
|
|
2022
Q3 | $262K | Buy |
+3,172
| New | +$262K | ﹤0.01% | 301 |
|
|
2022
Q2 | – | Sell |
-2,314
| Closed | -$272K | – | 330 |
|
|
2022
Q1 | $272K | Buy |
2,314
+190
| +9% | +$22.3K | ﹤0.01% | 317 |
|
|
2021
Q4 | $275K | Hold |
2,124
| – | – | ﹤0.01% | 313 |
|
|
2021
Q3 | $240K | Hold |
2,124
| – | – | ﹤0.01% | 324 |
|
|
2021
Q2 | $220K | Buy |
+2,124
| New | +$220K | ﹤0.01% | 333 |
|